We’re delighted to announce that OCEANIUM is a partner of the PRECODE research project conducted by the Wageningen University & Research, division of Human Nutrition & Health, studying gut and brain health effects of prebiotics in older adults with suspected cognitive decline, including conditions such as Alzheimer’s and dementia.
The aim is to investigate the gut and brain health effects of three prebiotic supplements, one of which is an OCEANIUM bioactive – OCEAN ACTIVES® Beta-glucan.
We’re extremely proud to be part of the first trial of its kind on seaweed Beta-glucan and we’re very much looking forward to beginning this project in 2023 to learn more about the health benefits of this fantastic bioactive ingredient.
– Charlie Bavington, Co-Founder and CTO at OCEANIUM
“OCEANIUM is privileged to have been invited to join PRECODE research project, it is such a great opportunity to work with the world-class research team at Wageningen University to have our novel beta-glucan product evaluated in a clinical trial studying the gut-brain axis in subjects with suspected cognitive decline. A great example of OCEANIUM delivering its mission for People Health and Planet Health.”